Save to favorites
This feature is restricted to active members.
Join now to save favorites and get all member benefits, including over 1,400 product reviews.
Join NowAlready a member? Sign in here.
Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted January 01, 2026
Herbal Supplements for Pain, Allergies Recalled
On November 20, 2025, A New Life Herbs, LLC, recalled four herbal supplements because they do not have a Supplement Facts label.
(See ConsumerLab's articles about supplements for arthritis and for seasonal allergies.)
The recalled products were distributed in Alabama, Arizona, California, Georgia, Illinois, Indiana, Minnesota, Missouri, Mississippi, North Carolina, New York, and Tennessee. Use the links below for more details, including UPC and expiration codes:
- Pain Away Herbal Supplement (4.5 or 9 oz bottle) – Contains wood betony & white willow in vegetable glycerin and is promoted for treating pain and inflammation.
- Boswellia Herbal Supplement (2 oz. glass dropper bottle) – Extract derived from frankincense and marketed for pain and inflammation.
- Baby Allergy Herbal Supplement (2 oz. glass dropper bottle) – Liquid herbal supplement containing echinacea, Oregon grape root, dandelion, burdock root, fenugreek, and ginger and promoted for allergies.
- Anti-virus Herbal Supplement (2 oz. glass dropper bottle) – Tincture containing forsythia blossoms, sumac berries, and pine needles and marketed to stop viral replication and provide expectorant effects.
See related recalls and warnings:
Major Retailers Accused of Selling Adulterated Herbal Supplements
Mixing Herbal Supplements, Migraine Medications Can Be Dangerous
Report a Problem
If you have experienced an unexpected and adverse reaction to a dietary supplement, nutritional product, or generic drug, we would like to hear about it, as we may investigate the problem. Please select from one of these options:
Dietary Supplement or Nutritional Product Problem Report
Thank you for submitting your report to ConsumerLab. We have received your information, and it has been forwarded to our research team for review.
Due to the volume of reports we receive, we may not be able to respond individually. However, all submissions are carefully reviewed and may be investigated. We may publish information from this report, and/or it may help guide future testing or research.
